A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/402 (2006.01) A61K 31/428 (2006.01) A61K 31/4704 (2006.01) A61P 11/00 (2006.01)
Patent
CA 2563302
A medicament comprising, separately or together (A) glycopyrrolate; and (B) either a compound of formula (I) in free or salt or solvate form, wherein W, Rx, Ry, R1, R2, R3, R4, R5, R6 and R7 have the meanings as indicated in the specification, or a compound of formula (II) in free or salt or solvate form, wherein X has the meaning as indicated in the specification, for simulataneous, sequential or separate administration in the treatment of an inflammatory or obstructive airways disease. Pharmaceutical compositions that contain (A) and (B) are also described.
Cette invention concerne un médicament comprenant, séparément ou conjointement, (A) un glycopyrrolate; et (B) soit un composé de formule (I) sous forme libre, sous forme de sel ou sous forme de solvate, dans laquelle W, R?x¿, R?y¿, R?1¿, R?2¿, R?3¿, R?4¿, R?5¿, R?6¿ et R?7¿ ont les notations indiquées dans les pièces descriptives de la demande, soit un composé de formule (II) sous forme libre, sous forme de sel ou sous forme de solvate, dans laquelle X possède la notation indiquée dans les pièces descriptives de la demande, en vue d'une administration simultanée, séquentielle ou séparée dans le traitement des maladies inflammatoires ou obstructives des voies respiratoires. Cette invention concerne également des compositions pharmaceutiques qui contiennent (A) et (B).
Fetherstonhaugh & Co.
Novartis Ag
LandOfFree
Combinations of glycopyrrolate and beta2 adrenoceptor agonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Combinations of glycopyrrolate and beta2 adrenoceptor agonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combinations of glycopyrrolate and beta2 adrenoceptor agonists will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1917016